Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Zimmer Biomet Holdings (0QQD) Share Price & Analysis

1 Followers

0QQD Stock Chart & Stats

CHF 77.38CHF 0.00(0.00%)
At close: 4:30 PM GMT
No data to display
Day’s Range
CHF 77.38 - CHF 77.38
52-Week Range
CHF 77.38 - CHF 77.38
Previous Close
CHF 77.38
Volume
N/A
Average Volume (3M)
0
Market Cap
CHF 16.99B
Enterprise Value
CHF 24.12B
Total Cash (Recent Filing)
CHF 399.90M
Total Debt (Recent Filing)
CHF 7.50B
Price to Earnings (P/E)
26.4
Beta
0.04
Next Earnings
Feb 11, 2027 (Est.)
EPS Estimate
2.06
Next Dividend Ex-Date
N/A
Dividend Yield
1.08%

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Portfolio Breadth

Zimmer Biomet combines a multi-year upward revenue trajectory with broad momentum across hips, S.E.T., technology and data. This diversification reduces reliance on one product line, supports recurring procedure-driven demand, and gives the company multiple avenues to sustain growth over the next several quarters.

Strong Cash Generation

Strong operating and free cash flow provide internal funding for innovation, commercial investment, acquisitions and shareholder returns. Management also expects full-year free cash flow growth of 9% to 11%, indicating that cash generation remains an important durable support for financial flexibility.

Technology And Robotics Expansion

Fast growth in robotics, data and AI expands Zimmer Biomet beyond traditional implants and can deepen surgeon and hospital engagement. Its installed technology base, planned robotic salesforce expansion and earlier Monogram timeline create longer-term opportunities for adoption and recurring procedure-related demand.

Bears Say

Knee Franchise Weakness

The knee franchise remains a meaningful area of weakness, with declines in both U.S. and international markets and management expecting continued near-term pressure. Persistent underperformance could dilute growth from stronger hip and technology categories and indicates unresolved commercial execution challenges.

Margin Pressure

Lower gross and operating margins show that revenue growth is not converting fully into earnings because of manufacturing costs and continued U.S. commercial investment. If these pressures persist, they could constrain earnings growth, reduce operating leverage and limit the benefits of stronger product mix.

Higher Leverage And Uneven Cash Growth

Moderately higher leverage reduces financial flexibility compared with earlier periods, particularly while the company is investing in its salesforce, manufacturing and technology platforms. Uneven free cash flow growth adds uncertainty to the pace at which Zimmer Biomet can fund initiatives and return capital.

Zimmer Biomet Holdings News

0QQD FAQ

What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest share price was CHF77.38 and its highest was CHF77.38 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Zimmer Biomet Holdings’s market cap is CHF16.99B.
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s next earnings report is estimated for Feb 11, 2027 (not yet confirmed), which is in 90 days.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on Nov 04, 2026. The company reported CHF1.568 earnings per share for the quarter, beating the consensus estimate of CHF1.553 by CHF0.016.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings does not currently pay dividends.
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate is 2.06.
How many shares outstanding does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings has 189,253,890 shares outstanding.
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of CHF1.568 in its last earnings report, beating expectations of CHF1.553. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Hedge funds hold Zimmer Biomet Holdings shares: the largest hedge-fund position in Zimmer Biomet Holdings is 1,133,105,916 shares, and hedge funds increased their holdings by 1.4M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology